A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson’s (ASAP) initiative.
Stroke patients received clot-busting medication more quickly,and had better recoveries, when treated by an ambulance-basedmobile stroke unit (MSU) compared with standard emergency room (EMS) care.
Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, according to a study of their effectiveness by a Weill Cornell Medicine and NewYork-Presbyterian investigator and collaborating colleagues in the Pediatric Epilepsy Research Consortium.
The degree to which the brain’s wiring aligns with its patterns of activity can vary with sex and age, and may be genetic, suggests a study published by Weill Cornell Medicine investigators.
People who have experienced a cerebral hemorrhage or brain bleed have a two-fold increase in the risk of having an ischemic stroke (caused by an artery blockage) or heart attack, compared with members of the general population.
Last spring, as the COVID-19 pandemic hit New York City with full force, Dr. Daniel MacGowan, a neurologist specializing in neuromuscular disease, was asked to consult in a COVID recovery ward.
More than 50 doctors, nurses and other healthcare professionals from Cayuga Health in Ithaca have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New Yorkers diagnosed with COVID-19.
The gene mutation that underlies a puzzling disorder featuring skin, brain and other abnormalities has been discovered by a team of scientists from Weill Cornell Medicine and the Fédération Hospitalo-Universitaire TRANSLAD (FHU-TRANSLAD) in France.
Personalized medical interventions to improve cardiovascular, metabolic and other modifiable risk factors for Alzheimer’s disease may improve cognitive function, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
The powerful but temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a new study.
